10/28/2026
Pharma giants invest billions in psychedelics despite hurdles
Psychedelics like MDMA and psilocybin gain traction amid regulatory challenges.
Topic archive
2 stories
10/28/2026
Psychedelics like MDMA and psilocybin gain traction amid regulatory challenges.
9/10/2026
The FDA highlights its evolving approach to psychedelic therapies amid a mental health crisis.